Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities
March 22 2023 - 12:00PM
Business Wire
– Funding Will Reach Under-Resourced
Communities Impacted by the HIV Epidemic as Part of Gilead’s
Zeroing In™: Ending the HIV Epidemic Grant Program –
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is
providing a total of $3 million in grant funding to eight
organizations to provide services to communities disproportionately
impacted by HIV in rural areas in the United States. My Brother’s
Keeper, based in Ridgeland, Mississippi, will provide technical
assistance and capacity building to the organizations funded
through this initiative. These grants are part of Gilead’s ongoing
Zeroing In™ program to help end the HIV epidemic by supporting
organizations working to improve the overall health and wellness of
communities most impacted by the HIV epidemic.
While HIV is prevalent in both urban and rural communities in
the United States, resources are heavily concentrated in urban
centers, and lack of public health infrastructure and heightened
stigma in rural communities create barriers of access to necessary
care. Gilead selected the grantees due to their strategic,
community-driven approaches toward dismantling these systemic
barriers that prevent people in rural communities from accessing
quality HIV testing and treatment. Through this investment, Zeroing
In rural health equity and advancement organizations will build on
their progress to strengthen public health infrastructure, address
HIV-related stigma and provide important resources to
under-resourced populations.
“Gilead is proud to go where the need is greatest and continue
to provide support to organizations that are working to provide
integral services to rural communities in the U.S. that have long
struggled to receive HIV care,” said Jane Stafford, Executive
Director, Public Affairs, Gilead Sciences. “These grants will allow
organizations to expand their testing programs, provide their
communities with access to necessary resources and fight stigma by
promoting a culture of compassion and inclusion. It takes more than
medicine to end the HIV epidemic and by supporting these
organizations, we’re increasing their capacity to educate
communities, change perceptions and provide critical access to
healthcare where it’s needed most.”
The eight Gilead Zeroing In rural health equity and advancement
grantees are:
- Alliance Of AIDS Services-Carolina (Raleigh, North
Carolina)
- Central Illinois Friends Inc. (Peoria, Illinois)
- Compassionate Atlanta Inc. (Atlanta, Georgia)
- Empowering Transgender Services Inc. (Hampton, Virginia)
- Helping Everyone Receive Ongoing Effective Support Inc.
(Columbia, Louisiana)
- My Brother’s Keeper Inc. (Ridgeland, Mississippi)
- Pierce County AIDS Foundation (Tacoma, Washington)
- Power Safe Place Resource Center of Virginia (Front Royal,
Virginia)
“My Brother’s Keeper is excited to help support the recipients
of Gilead’s Zeroing In rural health equity and advancement grants
with needed capacity building assistance,” said June Gipson, Ph.D.,
President and Chief Executive Officer, My Brother’s Keeper.
“Ensuring that rural communities have equal access and utilization
of HIV prevention, care and supportive services is an integral step
in combating inequity in HIV health outcomes. Gilead has long been
at the forefront of tackling structural and social barriers to HIV
care and treatment, and we are proud to work with them to impact
change.”
Launched in 2021, the Gilead Zeroing In grant program provides
support to organizations whose programs aim to increase the overall
health and wellness of communities most impacted by HIV.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has
pursued and achieved breakthroughs in medicine for more than three
decades, with the goal of creating a healthier world for all
people. The company is committed to advancing innovative medicines
to prevent and treat life-threatening diseases, including HIV,
viral hepatitis and cancer. Gilead operates in more than 35
countries worldwide, with headquarters in Foster City,
California.
Gilead has promoted equity, particularly healthcare equity,
since the company brought its first therapies to the market.
Through global partnerships, Gilead’s medicines today reach
millions of people in low- and middle-income countries around the
world. In the United States, Gilead has committed more than $100
million over 10 years through the COMPASS Initiative® to community
organizations that are working to combat HIV in the U.S. South. In
2020, Gilead launched the Racial Equity Community Impact Fund to
support organizations tackling racial inequities affecting Black
communities across the United States.
About the Gilead Zeroing In Grant
Program
Zeroing In builds on previous Gilead funding and grant programs,
while supporting organizations to increase the overall health and
wellness of communities most impacted by HIV and COVID-19. Gilead
provides support to organizations whose programs align with
international and country-specific goals of the Ending the HIV
Epidemic initiative. This includes local community programming and
coalition-led proposals from organizations collaborating to end the
HIV epidemic in their respective city, state, country or region.
Zeroing In programming focuses on comprehensive HIV innovation,
digital health innovation, and/or community outreach and
education.
For more information on Gilead’s Zeroing In grant program to
help end the HIV epidemic, please visit
https://www.gilead.com/purpose/giving/zeroing-in-ending-hiv-epidemic.
GILEAD, the GILEAD Logo, ZEROING IN and COMPASS
INITIATIVE are trademarks of Gilead Sciences, Inc.
For more information about Gilead, please visit
the company’s website at www.gilead.com, follow Gilead on Twitter
(@Gilead Sciences) or call Gilead Public Affairs at 1-800-GILEAD-5
or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230320005679/en/
Hayley Home, Media Public_Affairs@gilead.com
Jacquie Ross, Investors Investor_relations@gilead.com
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024